Biomanufacturing has evolved from a traditional craft to a high-tech pillar of the global economy. It now makes up 10% of petrochemical products and has an annual growth rate over 20%. This great expansion shows its special ability to deal with big global problems. These problems include environmental sustainability and healthcare innovation. So biomanufacturing is one of the most active and promising fields in the 21st century.
1.The current pattern of biomanufacturing.
Looking at its development, Professor Zhuang Yingping is the Dean of the School of Biotechnology at East China University of Science and Technology. She has clearly listed four stages that mark the development of industrial biomanufacturing. It starts with ancient solid-state fermentation methods for making wine and vinegar. Then it moved to anaerobic fermentation for primary metabolites. Next came aerobic liquid fermentation for secondary metabolites. Today, it is in the fourth stage. Synthetic biology and gene editing drive this stage. They let biomanufacturing meet important social needs. These needs include food security, carbon neutrality and advanced disease treatment. Examples are artificial organs and cell therapies.
This many-stage development has made a diverse industrial structure for biomanufacturing. It is often called a “tripartite division” covering three main sectors. Green biomanufacturing focuses on agriculture. It includes gene-edited crops, biopesticides and agricultural microorganisms. It helps make agriculture friendly to the environment and efficient. This reduces the need for chemical inputs. White biomanufacturing serves industrial needs.
It has bioenergy sources like ethanol and hydrogen. It also has biodegradable materials such as PLA and PHA, and industrial enzymes. It gives sustainable choices to traditional high-pollution chemical manufacturing processes. Red biomanufacturing centers on medicine. It drives new developments in recombinant protein drugs, nucleic acid therapies, vaccines and artificial organs. It becomes the backbone of biomedical progress and improves global health results. These sectors together show the versatility of biomanufacturing. They prove it can change industries in many areas.
Biomanufacturing’s main advantage is its “sustainable efficiency revolution”. It combines environmental friendliness with high-performance products. In the cosmetics industry, for example, vitamin B5 has been successfully made on an industrial scale. This happened through metabolic pathway optimization and fermentation process improvements. Different from chemical-made versions, biomanufactured vitamin B5 is closer to natural sources.
This makes it more compatible with human skin and improves absorption rates. Another notable success is the production of hyaluronic acid. Process optimization has pushed its fermentation yield to 28.7g/L. This breakthrough got rid of the limits of traditional extraction from animal tissues. It reduces costs and ensures a more consistent, scalable supply. This shows how biomanufacturing can change production standards in different sectors. Similar progress is seen in biopharmaceuticals. Biomanufacturing allows large-scale production of complex drugs. These drugs have higher purity and fewer side effects than traditional methods.
2.What is the problem?
But even with these great successes, biomanufacturing faces a big problem. It is called the pilot-scale “valley of death”. This is a major barrier that stops lab innovations from becoming large-scale industrial production. Professor Zhuang Yingping says that the root cause of this problem is the extreme complexity of biological systems.
This leads to unpredictable differences between lab experiments and industrial operations. Inside cells, the “cell factory” works as a very complicated network. Genes and metabolic pathways are closely connected. The flow of substances and energy in cells follows complex, non-linear patterns. These are hard to copy or control outside controlled lab conditions. Even small changes in genetic expression or metabolic flux can cause big differences in product yield or quality.
Outside cells, the environment in large bioreactors brings more problems for biomanufacturing. Small lab reactors have fairly consistent conditions, but large ones have “gradient fields” of nutrients, temperature and oxygen.
These gradients come from the large size of the equipment. Factors like agitator speed, baffle design and liquid circulation can create microenvironments. These microenvironments are very different in different parts of the reactor. Professor Zhuang points out that even small changes to these design elements can make production efficiency change by over 10%. This makes it very hard to keep the stable conditions needed for good biomanufacturing results.
Also, microorganisms go through changes in their physiological states during fermentation. These states include lag phase, exponential growth and stationary phase. Each phase needs specific environmental parameters to keep optimal metabolic activity. If you do not adjust these parameters dynamically, the system will move away from its ideal state. This leads to lower yields, worse product quality or even complete process failure.
3.What to do now?
To get past these problems and close the pilot-scale gap, Professor Zhuang Yingping suggests a new way. It is based on bioprocess engineering. It combines multi-scale control with intelligent technologies.
This way is designed to deal with the inherent complexity of biomanufacturing. Multi-scale coordinated control works on three connected levels: gene scale, cellular scale and reactor scale. At the gene level, researchers choose and engineer high-performance microbial strains. They optimize their metabolic pathways to increase product synthesis and reduce byproduct formation. At the cellular scale, process parameters like temperature, pH and nutrient supply are adjusted carefully. This maximizes metabolic efficiency and keeps cells alive during the fermentation cycle. At the reactor scale, computational fluid dynamics simulations are used. They model and improve reactor design.
This ensures uniform distribution of nutrients, oxygen and temperature. It also reduces the impact of gradient fields. By putting these three scales together, this method creates a smooth, cooperative system. Each part is optimized to support the others. This greatly improves the consistency and scalability of biomanufacturing processes.
Intelligent technologies have an important role in improving the precision and efficiency of biomanufacturing. They work with multi-scale control through real-time data-driven decision-making. New sensors—like online Raman and infrared sensors—let researchers monitor key cellular metabolites continuously. They also monitor nutrient concentrations and environmental conditions. This gives researchers real-time information about the biomanufacturing process.
Then this data is put into simple mathematical models. These models predict how changes in process parameters will affect product yield and quality. By using machine learning and artificial intelligence, these models can find optimal operating conditions. They can detect possible process deviations early.
They can even use adaptive control strategies to adjust parameters automatically. This “autonomous decision-making” ability cuts down the need for manual help. It reduces trial-and-error costs and improves the stability and reliability of pilot-scale biomanufacturing. Over time, these intelligent systems can learn from past data. They keep optimizing processes and driving further improvements in efficiency and scalability.
结论
Bailun FermentorChina promotes the intelligence of bioreactors, builds a big model for biological reactions and an end-to-end platform for synthetic biology covering “strain-to-industrial production”, and establishes a big data cloud platform for precision fermentation. It gathers massive reaction data, real-time monitors, analyzes and predicts fermentation parameters and substance changes, improves the efficiency and accuracy of synthetic biology R&D, and drives the intelligent, efficient and sustainable development of the biological industry. 联系我们
